{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:17:47Z","timestamp":1760955467923},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"DOI":"10.1093\/ajh\/hpu027","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T20:34:19Z","timestamp":1394224459000},"page":"1052-1060","source":"Crossref","is-referenced-by-count":18,"title":["Achieved Blood Pressures in the Secondary Prevention of Small Subcortical Strokes (SPS3) Study: Challenges and Lessons Learned"],"prefix":"10.1093","volume":"27","author":[{"given":"Pablo E.","family":"Pergola","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Texas Health Sciences Center at San Antonio and Renal Associates PA, San Antonio, Texas;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole L.","family":"White","sequence":"additional","affiliation":[{"name":"School of Nursing, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff M.","family":"Szychowski","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Talbert","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Texas at Austin, Austin, Texas;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar del","family":"Brutto","sequence":"additional","affiliation":[{"name":"Department of Neurological Sciences, Hospital-Cl\u00ednica Kennedy, and School of Medicine, Universidad Esp\u00edritu Santo\u2013Ecuador, Guayaquil, Ecuador;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar","family":"Castellanos","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitari Dr. Josep Trueta of Girona, Barcelona, Spain;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Graves","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension College of Medicine, Mayo Clinic, Rochester, Minnesota;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Matamala","sequence":"additional","affiliation":[{"name":"Unidad de Neurologia, Hospital Naval A. Nef, Vina del Mar, Chile;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin Javier","family":"Pretell","sequence":"additional","affiliation":[{"name":"Hospital Alberto Sabogal, Lima, Peru;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Yee","sequence":"additional","affiliation":[{"name":"Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Rebello","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalhousie University, Halifax, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar R.","family":"Benavente","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Brain Research Center, University of British Columbia, Vancouver, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the SPS3 Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,3,7]]},"reference":[{"key":"key\n\t\t\t\t20180328160302_CIT0001","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328160302_CIT0002","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/01.STR.28.12.2557","article-title":"Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators","volume":"28","author":"Gueyffier","year":"1997","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20180328160302_CIT0003","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328160302_CIT0004","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/01.STR.0000092488.40085.15","article-title":"Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review","volume":"34","author":"Rashid","year":"2003","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20180328160302_CIT0005","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0140-6736(11)60516-3","article-title":"Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328160302_CIT0006","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.07.001","article-title":"Awareness, treatment, and control of vascular risk factors among stroke survivors","volume":"19","author":"Brenner","year":"2010","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"key\n\t\t\t\t20180328160302_CIT0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1503\/cmaj.121819","article-title":"Why is controlling blood pressure after stroke so difficult?","volume":"185","author":"Dawes","year":"2013","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20180328160302_CIT0008","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/CIRCOUTCOMES.110.959809","article-title":"Prevalence of inadequate blood pressure control among veterans after acute ischemic stroke hospitalization: a retrospective cohort","volume":"4","author":"Roumie","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key\n\t\t\t\t20180328160302_CIT0009","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/ajh\/hpt076","article-title":"Blood pressure after recent stroke: baseline findings from the Secondary Prevention of Small Subcortical Strokes trial","volume":"26","author":"White","year":"2013","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20180328160302_CIT0010","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328160302_CIT0011","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328160302_CIT0012","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328160302_CIT0013","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1747-4949.2010.00573.x","article-title":"The Secondary Prevention of Small Subcortical Strokes (SPS3) study","volume":"6","author":"Benavente","year":"2011","journal-title":"Int J Stroke"},{"key":"key\n\t\t\t\t20180328160302_CIT0014","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.03.002","article-title":"Clinical features and racial\/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial","volume":"22","author":"White","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"key\n\t\t\t\t20180328160302_CIT0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000108861","article-title":"Lacunar infarcts\u2014a review","volume":"1","author":"Fisher","year":"1991","journal-title":"Cerebrovasc Dis"},{"key":"key\n\t\t\t\t20180328160302_CIT0016","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328160302_CIT0017","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.HYP.0000150859.47929.8e","article-title":"Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research","volume":"45","author":"Pickering","year":"2005","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180328160302_CIT0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MBP.0b013e3280858d5b","article-title":"Reliability and validity of blood pressure measurement in the Secondary Prevention of Small Subcortical Strokes study","volume":"12","author":"Pergola","year":"2007","journal-title":"Blood Press Monitoring"},{"key":"key\n\t\t\t\t20180328160302_CIT0019","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"283","author":"The ALLHAT Officers and Coordinators for the ALLHAT Collabortive Research Group","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328160302_CIT0020","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(04)17355-8","article-title":"Atenolol in hypertension: is it a wise choice?","volume":"364","author":"Carlberg","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328160302_CIT0021","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archinte.165.12.1401","article-title":"Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"165","author":"Whelton","year":"2005","journal-title":"Arch Int Med"},{"key":"key\n\t\t\t\t20180328160302_CIT0022","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/003693305700200504","article-title":"Cerebral vascular accidents in patients over the age of 60. II. Prognosis","volume":"2","author":"Rankin","year":"1957","journal-title":"Scott Med J"},{"key":"key\n\t\t\t\t20180328160302_CIT0023","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"The SPS3 Study Group","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328160302_CIT0024","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/HJH.0b013e328353968d","article-title":"Predictors of lowering SBP to assigned targets at 12 months in the Secondary Prevention of Small Subcortical Strokes study","volume":"30","author":"Graves","year":"2012","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20180328160302_CIT0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","article-title":"Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT)","volume":"4","author":"Cushman","year":"2002","journal-title":"J Clin Hypertens"},{"key":"key\n\t\t\t\t20180328160302_CIT0026","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"The ACCORD Study Group","year":"2010","journal-title":"New Engl J Med"},{"key":"key\n\t\t\t\t20180328160302_CIT0027","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1751-7176.2011.00491.x","article-title":"Impacting population cardiovascular health through a community-based practice network: update on an ASH-supported collaborative","volume":"13","author":"Egan","year":"2011","journal-title":"J Clin Hypertens"},{"key":"key\n\t\t\t\t20180328160302_CIT0028","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/jama.2013.282615","article-title":"Protocol-based treatment of hypertension: a critical step on the pathway to progress","volume":"311","author":"Frieden","year":"2014","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328160302_CIT0029","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/fampra\/cmp075","article-title":"Effectiveness of a protocol-based strategy for achieving better blood pressure control in general practice","volume":"27","author":"Godwin","year":"2010","journal-title":"Fam Pract"},{"key":"key\n\t\t\t\t20180328160302_CIT0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/01.mlr.0000220260.30768.32","article-title":"Quality improvement strategies for hypertension management: A systematic review","volume":"44","author":"Walsh","year":"2006","journal-title":"Med Care"},{"key":"key\n\t\t\t\t20180328160302_CIT0031","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(13)62038-3","article-title":"Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial","volume":"383","author":"Derdeyn","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328160302_CIT0032","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1001\/archinte.165.18.2098","article-title":"Racial disparities in hypertension prevalence, awareness, and management","volume":"165","author":"Hertz","year":"2005","journal-title":"Arch Int Med"},{"key":"key\n\t\t\t\t20180328160302_CIT0033","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/01.STR.0000217222.09978.ce","article-title":"Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study","volume":"37","author":"Howard","year":"2006","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20180328160302_CIT0034","first-page":"421","article-title":"Understanding racial disparities in hypertension control: intensity of hypertension medication treatment in the REGARDS study","volume":"17","author":"Safford","year":"2007","journal-title":"Ethn Dis"},{"key":"key\n\t\t\t\t20180328160302_CIT0035","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/jama.293.13.1595","article-title":"Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril","volume":"293","author":"Wright","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328160302_CIT0036","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajh\/article-pdf\/27\/8\/1052\/17046508\/hpu027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T23:45:55Z","timestamp":1522280755000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/27\/8\/1052\/2743252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,7]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,3,7]]},"published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpu027","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"type":"print","value":"0895-7061"},{"type":"electronic","value":"1941-7225"}],"subject":[],"published":{"date-parts":[[2014,3,7]]}}}